Cerecin's Series E Round

Cerecin raised a round of funding on December 21, 2010.

Cerecin, fka Accera, is a biopharmaceutical company with a drug for Alzheimer's in late stage clinical testing. Accera's pipeline consists of therapeutic drugs and medical foods for neurodegenerative …

Articles about Cerecin's Series E Round: